To prohibit Federal funding to the Wuhan Institute of Virology and to require a GAO study regarding Federal funds previously provided to such institute or to entities affiliated with the Chinese Government.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The bill creates prohibition on Federal funding to the Wuhan Institute of Virology No funds authorized or appropriated by Federal law may be made available to the Wuhan Institute of Virology for any purpose. It relies on appropriations, grants, reporting requirements, and compliance mandates. The main policy areas are Regulated Industries and Science & Space.
Who Benefits and How
Public beneficiaries or protected communities affected by the clause could face reduced risk.
Who Bears the Burden and How
Federal, state, or local agencies responsible for implementing the clause would take on compliance duties and Researchers and scientific institutions affected by the bill would take on compliance duties.
Key Provisions
- Creates prohibition on Federal funding to the Wuhan Institute of Virology No funds authorized or appropriated by Federal law may be made available to the Wuhan Institute of Virology for any purpose.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill creates prohibition on Federal funding to the Wuhan Institute of Virology No funds authorized or appropriated by Federal law may be made available to the Wuhan Institute of Virology for any purpose.
Key Policy Areas
Regulated Industries, Science & Space
Primary Purpose
The bill creates prohibition on Federal funding to the Wuhan Institute of Virology No funds authorized or appropriated by Federal law may be made available to the Wuhan Institute of Virology for any purpose.
Policy Domains
Whole bill
Identified Gains
- Public beneficiaries or protected communities affected by the clause
Identified Costs
- Federal, state, or local agencies responsible for implementing the clause
- Researchers and scientific institutions affected by the bill
Sponsors
Legislative Progress
IntroducedMr. Perry (for himself, Mr. Tiffany, Mr. Ogles, Mr. Norman, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology